Demineralized Bone Matrix Market - By Product Type (Gel, Putty, Sponge, Fiber, Paste), Application (Dental, Craniomaxillofacial, Joint Reconstruction, Spinal Fusion), End-use (Hospitals, Specialty Clinics) - Global Forecast, 2024 - 2032

Demineralized Bone Matrix Market is poised to expand at 4.9% CAGR from 2024 to 2032 due to the rising incidence of orthopedic conditions globally. Factors, such as increasing aging population, sports-related injuries, and degenerative bone diseases are contributing to the demand for demineralized bone matrix (DBM) products in orthopedic surgeries. The ability of DBM to promote bone healing and regeneration in fractures, spinal fusions, and joint reconstructions is surging its preference among surgeons.

Additionally, surgeons rely on the osteoinductive properties offered by DBM to facilitate successful bone repair. With the rising prevalence of orthopedic disorders, the demand for DBM is rising, thereby providing potential growth opportunities to the industry players. For instance, in October 2023, Irvine-based Biogennix, an osteobiologics firm that creates, manufactures, and markets unique bone graft materials for bone fusion surgeries, introduced the new OsteoSPAN Fiber Matrix, made entirely of demineralized cortical fibers.

The demineralized bone matrix industry is segmented into product type, application, end-use, and region.

Based on product type, the market size from the fiber segment is anticipated to record 4.6% CAGR from 2024-2032. DBM fibers offer enhanced handling and versatility in various orthopedic applications, such as spinal fusions and bone grafting procedures. They also provide a scaffold for bone regeneration, promoting new bone formation and integration with surrounding tissues. Surgeons prefer DBM fibers for their ease of use and ability to conform to complex anatomies. Additionally, the superior osteoinductive properties of these fibers to accelerate the healing process is fueling their adoption.

In terms of application, the demineralized bone matrix market from the dental segment is projected to witness 5.1% growth rate between 2024 and 2032. This is owing to the widespread use of DBM in dental surgeries for its ability to promote bone regeneration and enhance implant success rates. Dental procedures, such as socket preservation, sinus lifts, and periodontal surgeries benefit from the osteoinductive properties of DBM, aiding in bone healing and integration. The growing demand for dental implants and oral surgeries coupled with the rising prevalence of dental disorders is boosting the use of DBM in the dental field.

Given the regional landscape, the Asia Pacific demineralized bone matrix industry generated considerable revenue in 2023 and is set to exhibit 5.5% CAGR through 2032. The growth is due to the large and aging population, coupled with increasing incidences of orthopedic and dental conditions in the region. The rising healthcare expenditure is making way for improving healthcare infrastructure. Moreover, government initiatives for promoting advanced medical technologies and investments in R&D are contributing to the regional industry expansion.